查看购物车
  • Traditional Chinese
  • English
  • Japanese
亚太地区基因分型市场预测至 2031 年 - 区域分析 - 按产品类型、技术、应用、最终用户
市场调查报告书
商品编码
1666234

亚太地区基因分型市场预测至 2031 年 - 区域分析 - 按产品类型、技术、应用、最终用户

Asia Pacific Genotyping Market Forecast to 2031 - Regional Analysis - by Product Type, Technology, Application, End user
出版日期: | 出版商: The Insight Partners | 英文 160 Pages | 订单完成后即时交付

价格

2023 年亚太地区基因分型市值为 64.8996 亿美元，预计到 2031 年将达到 350.4862 亿美元；预计 2023 年至 2031 年的复合年增长率将达到 23.5%。

应用范围不断扩大，推动亚太地区基因分型市场发展

基因分型在诊断研究、药物基因体学和农业生物技术中具有潜在的应用。此外，该技术适用于各种植物育种、法医和环境测试程序。製药公司正在从多基因风险评分、与患者健康资讯相关的大量基因资料库以及临床试验参与者的测序资料等进步中获利。产业药物基因组学工作小组 (I-PWG) 是一个製药公司协会，积极参与药物基因组学研究。 I-PWG 由 26 家成员公司组成，每年进行大量临床试验，并根据协议收集研究对象的 DNA 样本。 I-PWG 专注于临床药物基因组学，旨在未来几年为製药公司创造机会。除了在肿瘤学研究中最频繁的用途外，它还用于非肿瘤学治疗领域（如罕见疾病、免疫学和心臟病学）进行的 PGx 研究。一项更全面的研究涉及临床试验样本的NGS，可以对试验参与者进行详细的基因组评估，揭示常见和罕见的基因变异。 PGx 包括研究基因组层级的药物/外来化合物效应、药物反应和疾病易感性以及基因型/表型关係中的多态性差异。

定序基因分型（GBS）是一种利用NGS方法对农作物基因组和人类基因组中的SNP进行定位和基因分型的新方法。 GBS 透过在定序过程中加入分子标记来开发和部署，用于对多个样本进行定序，以进一步增强 NGS 在玉米和小麦等大型作物基因组定序中的应用。 GBS检测的高通量SNP广泛应用于许多植物物种的遗传多样性分析、全基因组关联研究（GWAS）、QTL定位和基因组预测（GP）。 NGS技术以高通量和低成本改变了现代生物学。随着 NGS 技术的显着进步，全基因组定序提供了超通量序列，彻底改变了植物基因分型和育种。边合成边定序（SBS）和多路復用大大提高了序列的效率。

因此，各个研究领域更广泛地采用基因分型最终将导致对这些技术的需求增加，从而为市场创造巨大的机会。

亚太地区基因分型市场概览

亚太地区的基因分型市场细分为印度、中国、日本、澳洲、韩国和亚太其他地区。技术进步的激增、 DNA 测序价格的下降、亚洲和西方国家之间的合作（用于基因组研究的发展）的激增以及遗传疾病和其他目标疾病的患病率上升是推动亚太地区基因分型市场发展的因素之一。

亚太地区基因分型市场收入及预测（2031 年）（百万美元）

亚太地区基因分型市场细分

亚太地区基因分型市场分为产品类型、技术、应用、最终用户和国家。

根据产品类型，亚太地区基因分型市场分为仪器、试剂和试剂盒、生物资讯学和基因分型服务。试剂和试剂盒部分在 2023 年占据了最大的市场份额。

依技术划分，亚太地区基因分型市场分为微阵列、毛细管电泳、定序、聚合酶炼式反应 (PCR)、基质辅助雷射解吸/MALDI-TOF 和其他技术。聚合酶链反应 (PCR) 领域在 2023 年占据了最大的市场份额。

根据应用，亚太地区基因分型市场分为药物基因组学、诊断和个人化医疗、动物遗传学、农业生物技术和其他应用。 2023 年，诊断和个人化医疗领域占据最大的市场份额。

就最终用户而言，亚太地区基因分型市场分为製药和生物製药公司、诊断和研究实验室、学术机构和其他最终用户。 2023 年，製药和生物製药公司部门占据了最大的市场份额。

依国家划分，亚太基因分型市场分为中国、日本、印度、澳洲、韩国和亚太其他地区。 2023年，中国占据亚太地区基因分型市场的主导份额。

Hoffmann-La Roche Ltd、QIAGEN NV、Merck KGaA、XCELRIS GENOMICS、Thermo Fisher Scientific Inc、BioTek Instruments Inc、Illumina Inc、Danaher Corp、Bio-Rad Laboratories Inc、GE HealthCare Technologies Inc、Standard BioTools Inc、Laboratory Corp of America、Sooratory Corp of。是亚太地区基因分型市场的一些领导公司。

目录

第 1 章：简介

第 2 章：执行摘要

  • 关键见解

第三章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 发育基数：
    • 数据三角测量：
    • 国家级资料：

第 4 章：亚太地区基因分型市场格局

  • 概述
  • 全球市占率分析
    • NGS 文库製备主要参与者的全球市占率（%）
    • 基因分型领导企业的全球市场占有率（%）
    • 基因表现领域领导企业的全球市场占有率（%）

第 5 章：亚太地区基因分型市场 - 主要市场动态

  • 市场驱动因素：
    • 用于诊断遗传疾病和罕见疾病
    • 生物技术和製药行业的技术进步和研发投资不断增加
  • 市场限制
    • 设备成本高，专业技术人员短缺
  • 市场机会
    • 扩大应用范围
  • 未来趋势
    • 个人化医疗日益普及
  • 驱动因素和限制因素的影响：

第 6 章：基因分型市场 - 亚太地区分析

  • 2021 至 2031 年基因分型市场收入

第 7 章：亚太地区基因分型市场分析 - 依产品类型

  • 仪器
  • 试剂和试剂盒
  • 生物资讯学
  • 基因分型服务

第 8 章：亚太地区基因分型市场分析 - 按技术

  • 微阵列
  • 毛细管电泳
  • 定序
  • 聚合酶炼式反应（PCR）
  • 基质辅助雷射解吸/MALDI-TOF
  • 其他技术

第 9 章：亚太地区基因分型市场分析 - 按应用

  • 药物基因组学
  • 诊断及个人化医疗
  • 动物遗传学
  • 农业生物技术
  • 其他应用

第 10 章：亚太地区基因分型市场分析 - 依最终用户

  • 製药和生物製药公司
  • 诊断与研究实验室
  • 学术机构
  • 其他最终用户

第 11 章：亚太地区基因分型市场 - 国家分析

  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区

第 12 章：产业格局

  • 概述
  • 基因分型市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 13 章：公司简介

  • Hoffmann-La Roche Ltd
  • QIAGEN NV
  • Merck KGaA
  • EUROFINS GENOMICS
  • Thermo Fisher Scientific Inc
  • BioTek Instruments, Inc.
  • XCELRIS GENOMICS
  • TRIMGEN CORPORATION
  • Illumina Inc
  • Danaher Corp
  • Bio-Rad Laboratories Inc
  • GE HealthCare Technologies Inc
  • Standard BioTools Inc
  • Laboratory Corp of America Holdings
  • Beckman Coulter Inc
  • BGI
  • Takara Bio Inc
  • DiaSorin SpA

第 14 章：附录

Product Code: BMIRE00025968

The Asia Pacific genotyping market was valued at US$ 6,489.96 million in 2023 and is expected to reach US$ 35,048.62 million by 2031; it is estimated to record a CAGR of 23.5% from 2023 to 2031.

Expanding Range of Applications Boosts Asia Pacific Genotyping Market

Genotyping holds potential applications in diagnostic research, pharmacogenomics, and agricultural biotechnology. Moreover, this technique is suitable for a variety of plant breeding, forensic, and environmental testing procedures. Pharmaceutical companies are profiting from the availability of polygenic risk scores, substantial genetic databases linked to patient health information, and the sequencing data of clinical trial participants, among other advancements. The Industry Pharmacogenomics Working Group (I-PWG), an association of pharmaceutical companies, is actively involved in pharmacogenomic research. The I-PWG comprises 26member companies that undertake numerous clinical trials annually, collecting DNA samples of study subjects as part of the protocol. With its focus on clinical pharmacogenomics, the I-PWG aims to generate opportunities for pharmaceutical companies in the coming years. In addition to its most frequent use in oncology research, it is also used for PGx studies conducted in non-oncology therapeutic areas such as rare diseases, immunology, and cardiology. A more comprehensive study, involving the NGS of clinical trial samples, allows for an elaborate genomic evaluation of trial participants, revealing both common and rare genetic variations. PGx includes the study of polymorphic differences in the determination of genomic-level drug/xenobiotic effects, drug response and disease susceptibility, and genotype/phenotype relationships.

Genotyping-by-sequencing (GBS) is a new method to locate and genotype SNPs in crop genomes and human genome by using NGS methods. GBS is developed and deployed in sequencing multiple samples by incorporating molecular markers in the process to further enhance NGS applications in giant crop genome sequencing, such as maize and wheat. High-throughput SNPs detected by GBS are widely used in genetic diversity analysis, genome-wide association studies (GWAS), QTL mapping, and genome prediction (GP) in many plant species. NGS technology has transformed modern biology with high throughput and low cost. With remarkable advancements unlocked by NGS technologies, whole-genome sequencing provides ultra-throughput sequences that revolutionize plant genotyping and breeding. Sequencing by synthesis (SBS) and multiplexing greatly enhances the efficiency of the sequence.

Therefore, greater adoption of genotyping in various research areas would eventually lead to a rise in the demand for these techniques, creating significant opportunities in the market.

Asia Pacific Genotyping Market Overview

The genotyping market in Asia Pacific is sub-segmented into India, China, Japan, Australia, South Korea, and the Rest of Asia Pacific. An upsurge in technological advancements, decreasing prices of DNA sequencing, the surge in collaborations (for the development of genomic research) among Asian and Western countries, and the rising prevalence of genetic and other target diseases are among the factors propelling the APAC genotyping market.

Asia Pacific Genotyping Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Genotyping Market Segmentation

The Asia Pacific genotyping market is categorized into product type, technology, application, end user, and country.

Based on product type, the Asia Pacific genotyping market is segmented into instruments, reagents and kits, bioinformatics, and genotyping services. The reagents and kits segment held the largest market share in 2023.

By technology, the Asia Pacific genotyping market is segmented into microarrays, capillary electrophoresis, sequencing, polymerase chain reaction (PCR), matrix-assisted laser desorption / MALDI-TOF, and other technologies. The polymerase chain reaction (PCR) segment held the largest market share in 2023.

Based on application, the Asia Pacific genotyping market is bifurcated into pharmacogenomics, diagnostics and personalized medicine, animal genetics, agricultural biotechnology, and other applications. The diagnostics and personalized medicine segment held the largest market share in 2023.

In terms of end user, the Asia Pacific genotyping market is bifurcated into pharmaceutical and biopharmaceutical companies, diagnostic and research laboratories, academic institutes, and other end users. The pharmaceutical and biopharmaceutical companies segment held the largest market share in 2023.

By country, the Asia Pacific genotyping market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific genotyping market share in 2023.

Hoffmann-La Roche Ltd, QIAGEN NV, Merck KGaA, XCELRIS GENOMICS, Thermo Fisher Scientific Inc, BioTek Instruments Inc, Illumina Inc, Danaher Corp, Bio-Rad Laboratories Inc, GE HealthCare Technologies Inc, Standard BioTools Inc, Laboratory Corp of America Holdings, Beckman Coulter Inc, BGI, Takara Bio Inc, and DiaSorin SpA. are some of the leading companies operating in the Asia Pacific genotyping market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Asia Pacific Genotyping Market Landscape

  • 4.1 Overview
  • 4.2 Global Market Share Analysis
    • 4.2.1 Global Market Share (%) of Leading Players for NGS Library Preparation
    • 4.2.2 Global Market Share (%) of Leading Player for Genotyping
    • 4.2.3 Global Market Share (%) of Leading Player for Gene Expression

5. Asia Pacific Genotyping Market - Key Market Dynamics

  • 5.1 Market Drivers:
    • 5.1.1 Use in Diagnosis of Genetic and Rare Diseases
    • 5.1.2 Technological Advancements and Rising R&D Investments in Biotechnology and Pharmaceutical Industry
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Equipment and Shortage of Skilled Professionals
  • 5.3 Market Opportunities
    • 5.3.1 Expanding Range of Applications
  • 5.4 Future Trends
    • 5.4.1 Increasing Popularity of Personalized Medicine
  • 5.5 Impact of Drivers and Restraints:

6. Genotyping Market - Asia Pacific Analysis

  • 6.1 Genotyping Market Revenue (US$ Million), 2021-2031

7. Asia Pacific Genotyping Market Analysis - by Product Type

  • 7.1 Instruments
    • 7.1.1 Overview
    • 7.1.2 Instruments: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Reagents and Kits
    • 7.2.1 Overview
    • 7.2.2 Reagents and Kits: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Bioinformatics
    • 7.3.1 Overview
    • 7.3.2 Bioinformatics: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Genotyping Services
    • 7.4.1 Overview
    • 7.4.2 Genotyping Services: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Genotyping Market Analysis - by Technology

  • 8.1 Microarray
    • 8.1.1 Overview
    • 8.1.2 Microarray: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Capillary Electrophoresis
    • 8.2.1 Overview
    • 8.2.2 Capillary Electrophoresis: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Sequencing
    • 8.3.1 Overview
    • 8.3.2 Sequencing: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Polymerase Chain Reaction (PCR)
    • 8.4.1 Overview
    • 8.4.2 Polymerase Chain Reaction (PCR): Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Matrix-Assisted Laser Desorption / MALDI-TOF
    • 8.5.1 Overview
    • 8.5.2 Matrix-Assisted Laser Desorption / MALDI-TOF: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.6 Other Technologies
    • 8.6.1 Overview
    • 8.6.2 Other Technologies: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)

9. Asia Pacific Genotyping Market Analysis - by Application

  • 9.1 Pharmacogenomics
    • 9.1.1 Overview
    • 9.1.2 Pharmacogenomics: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Diagnostics and Personalized Medicine
    • 9.2.1 Overview
    • 9.2.2 Diagnostics and Personalized Medicine: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Animal Genetics
    • 9.3.1 Overview
    • 9.3.2 Animal Genetics: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Agricultural Biotechnology
    • 9.4.1 Overview
    • 9.4.2 Agricultural Biotechnology: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Other Applications
    • 9.5.1 Overview
    • 9.5.2 Other Applications: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)

10. Asia Pacific Genotyping Market Analysis - by End-user

  • 10.1 Pharmaceutical and Biopharmaceutical Companies
    • 10.1.1 Overview
    • 10.1.2 Pharmaceutical and Biopharmaceutical Companies: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Diagnostic and Research Laboratories
    • 10.2.1 Overview
    • 10.2.2 Diagnostic and Research Laboratories: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Academic Institutes
    • 10.3.1 Overview
    • 10.3.2 Academic Institutes: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Other End Users
    • 10.4.1 Overview
    • 10.4.2 Other End Users: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)

11. Asia Pacific Genotyping Market - Country Analysis

  • 11.1 Asia Pacific
    • 11.1.1 Asia Pacific: Genotyping Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.1 China: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.1.1.1 China: Genotyping Market Breakdown, by Product Type
        • 11.1.1.1.2 China: Genotyping Market Breakdown, by Technology
        • 11.1.1.1.3 China: Genotyping Market Breakdown, by Application
        • 11.1.1.1.4 China: Genotyping Market Breakdown, by End-user
      • 11.1.1.2 Japan: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.1.2.1 Japan: Genotyping Market Breakdown, by Product Type
        • 11.1.1.2.2 Japan: Genotyping Market Breakdown, by Technology
        • 11.1.1.2.3 Japan: Genotyping Market Breakdown, by Application
        • 11.1.1.2.4 Japan: Genotyping Market Breakdown, by End-user
      • 11.1.1.3 India: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.1.3.1 India: Genotyping Market Breakdown, by Product Type
        • 11.1.1.3.2 India: Genotyping Market Breakdown, by Technology
        • 11.1.1.3.3 India: Genotyping Market Breakdown, by Application
        • 11.1.1.3.4 India: Genotyping Market Breakdown, by End-user
      • 11.1.1.4 Australia: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.1.4.1 Australia: Genotyping Market Breakdown, by Product Type
        • 11.1.1.4.2 Australia: Genotyping Market Breakdown, by Technology
        • 11.1.1.4.3 Australia: Genotyping Market Breakdown, by Application
        • 11.1.1.4.4 Australia: Genotyping Market Breakdown, by End-user
      • 11.1.1.5 South Korea: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.1.5.1 South Korea: Genotyping Market Breakdown, by Product Type
        • 11.1.1.5.2 South Korea: Genotyping Market Breakdown, by Technology
        • 11.1.1.5.3 South Korea: Genotyping Market Breakdown, by Application
        • 11.1.1.5.4 South Korea: Genotyping Market Breakdown, by End-user
      • 11.1.1.6 Rest of APAC: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.1.6.1 Rest of APAC: Genotyping Market Breakdown, by Product Type
        • 11.1.1.6.2 Rest of APAC: Genotyping Market Breakdown, by Technology
        • 11.1.1.6.3 Rest of APAC: Genotyping Market Breakdown, by Application
        • 11.1.1.6.4 Rest of APAC: Genotyping Market Breakdown, by End-user

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Genotyping Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Hoffmann-La Roche Ltd
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 QIAGEN NV
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Merck KGaA
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 EUROFINS GENOMICS
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Thermo Fisher Scientific Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 BioTek Instruments, Inc.
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 XCELRIS GENOMICS
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 TRIMGEN CORPORATION
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Illumina Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Danaher Corp
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Bio-Rad Laboratories Inc
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 GE HealthCare Technologies Inc
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments
  • 13.13 Standard BioTools Inc
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Products and Services
    • 13.13.4 Financial Overview
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Developments
  • 13.14 Laboratory Corp of America Holdings
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments
  • 13.15 Beckman Coulter Inc
    • 13.15.1 Key Facts
    • 13.15.2 Business Description
    • 13.15.3 Products and Services
    • 13.15.4 Financial Overview
    • 13.15.5 SWOT Analysis
    • 13.15.6 Key Developments
  • 13.16 BGI
    • 13.16.1 Key Facts
    • 13.16.2 Business Description
    • 13.16.3 Products and Services
    • 13.16.4 Financial Overview
    • 13.16.5 SWOT Analysis
    • 13.16.6 Key Developments
  • 13.17 Takara Bio Inc
    • 13.17.1 Key Facts
    • 13.17.2 Business Description
    • 13.17.3 Products and Services
    • 13.17.4 Financial Overview
    • 13.17.5 SWOT Analysis
    • 13.17.6 Key Developments
  • 13.18 DiaSorin SpA
    • 13.18.1 Key Facts
    • 13.18.2 Business Description
    • 13.18.3 Products and Services
    • 13.18.4 Financial Overview
    • 13.18.5 SWOT Analysis
    • 13.18.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Genotyping Market Segmentation
  • Table 2. Genotyping Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 3. Genotyping Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 4. Genotyping Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 5. Genotyping Market - Revenue and Forecast to 2031 (US$ Million) - by End-user
  • Table 6. China: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 7. China: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 8. China: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 9. China: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 10. Japan: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 11. Japan: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 12. Japan: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 13. Japan: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 14. India: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 15. India: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 16. India: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 17. India: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 18. Australia: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 19. Australia: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 20. Australia: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 21. Australia: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 22. South Korea: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 23. South Korea: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 24. South Korea: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 25. South Korea: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 26. Rest of APAC: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 27. Rest of APAC: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 28. Rest of APAC: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 29. Rest of APAC: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 30. Recent Organic Growth Strategies in Genotyping Market
  • Table 31. Recent Inorganic Growth Strategies in the Genotyping Market
  • Table 32. Glossary of Terms, Genotyping Market

List Of Figures

  • Figure 1. Asia Pacific Genotyping Market Segmentation, by Country
  • Figure 2. Genotyping Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Genotyping Market Revenue (US$ Million), 2021-2031
  • Figure 5. Genotyping Market Share (%) - by Product Type (2023 and 2031)
  • Figure 6. Instruments: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Reagents and Kits: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Bioinformatics: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Genotyping Services: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Genotyping Market Share (%) - by Technology (2023 and 2031)
  • Figure 11. Microarray: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Capillary Electrophoresis: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Sequencing: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Polymerase Chain Reaction (PCR): Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Matrix-Assisted Laser Desorption / MALDI-TOF: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Other Technologies: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Genotyping Market Share (%) - by Application (2023 and 2031)
  • Figure 18. Pharmacogenomics: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Diagnostics and Personalized Medicine: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Animal Genetics: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Agricultural Biotechnology: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Other Applications: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Genotyping Market Share (%) - by End-user (2023 and 2031)
  • Figure 24. Pharmaceutical and Biopharmaceutical Companies: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 25. Diagnostic and Research Laboratories: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. Academic Institutes: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Other End Users: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Asia Pacific Genotyping Market, by Key Countries - Revenue (2023) (US$ Million)
  • Figure 29. Asia Pacific: Genotyping Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 30. China: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 31. Japan: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 32. India: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 33. Australia: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 34. South Korea: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 35. Rest of APAC: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 36. Growth Strategies in Genotyping Market